Upregulation of miR-1266-5p serves as a prognostic biomarker of triple-negative breast cancer and facilitates tumor cell proliferation, migration and invasion

Key Points

• Upregulation of miR-1266-5p significantly enhances tumor cell proliferation, migration, and invasion in triple-negative breast cancer.
• The study identifies miR-1266-5p as a potential prognostic biomarker relevant to patient outcomes in TNBC.
• Assessment involved analyzing the regulatory functions of microRNAs in tumorigenesis specifically within TNBC models.
• Further research on miR-1266-5p may lead to improved therapeutic strategies for triple-negative breast cancer.